Clinical Trial Site
Beirut 2807
1 studies enrolling now · 4 studies all time
What they study most
End Stage Renal Disease, Genetic Disease, Kidney Diseases, Primary Hyperoxaluria, Primary Hyperoxaluria Type 1, Primary Hyperoxaluria Type 1 (PH1), Primary Hyperoxaluria Type 2 (PH2), Primary Hyperoxaluria Type 3 (PH3), Urologic Diseases
Studies at this site
- Safety & Efficacy of DCR-PHXC in Patients With PH1 and ESRD — Recruiting now
- A Study to Evaluate Lumasiran in Patients With Advanced Primary Hyperoxaluria Type 1 — Completed
- Long Term Extension Study in Patients With Primary Hyperoxaluria — Running, not enrolling
- A Study to Evaluate DCR-PHXC in Children and Adults With Primary Hyperoxaluria Type 1 and Primary Hyperoxaluria Type 2 — Completed